 |
| |
ACCORD
Diabetes Study Stopped
More deaths in
the better blood sugar group?
(20080217) The ACCORD diabetes study released some unexpected news
recently. There have been more deaths in the experimental
group, that group of folks
aiming for A1c levels below 6% with aggressive medication treatments,
than the control treatment group. But please, don't read this far and
stop. Learn
more...
It may not be as clear cut as it appears. It could be
devistating for people to start running higher sugars based solely on
this. This type of news about a study should not be generalized until
more...MUCH MORE... is known. Also, there may be some positive news
that comes out of the ACCORD trial. Read on. First, some background
information:
What was the research about?
The ACCORD trial (Action to
Control Cardiovascular Risk in Diabetes) was not all about blood
sugars. The study wanted to learn if better than normal methods to
lower cholesterol, blood pressure and blood glucose levels would reduce
the risk of cardiovascular disease in type 2 diabetes. The
"experimental group" was given a more aggressive treatment of all these
variables. The "control group" was given a more standard treatment.
Who was in the study?
- Over 10,000 people with type 2 diabetes
- Subjects
were at higher risk for heart disease as had a history of heart
disease, obesity, smoking, high cholesterol or high blood pressure.
- There were located in 77 different centres
across the U.S. and Canada
What has the ACORD diabetes study found?
The
negative: There have been more deaths in the experimental
group than the control group.
The
positive: Both the experimental and the control groups
appear to have significantly less deaths per 1000 people than the
general population. The control group is supposed to
represent the general population however it is well know that people in
research studies receive better medical care and generally take better
care of themselves and may forget their medication less.
Why stop the study? Or was the study stopped?
Well, the first articles I read said the study was stopped. A bit of
digging led to an article that said it was not stopped. I
contacted a professional involved in the ACCORD trial to learn the
following as of Feb 14, 2008:
- The study is still going on
- The patients in the experimental group have all
been switched to the same proticol of medications as the control group.
- Preliminary analysis have not shown a
relationship between Avandia and the deaths.
- Preliminary analysis have not shown a
relationship between hypoglycemia and the deaths.
- There were numerous
variables in this research. As this study is put under the microscope,
we'll learn more.
In the mean time, remember there is excellent
research to say that better blood sugars reduce small blood vessel
complications to eyes, kidneys and nerves in type 2 diabetes
(UKPDS). The same research is available for type 1 diabetes (DCCT), and
includes the reduction of heart disease (EDIC study). Let's wait to see
what further analysis has to show.
On a personal note, my heart goes out to those who lost loved ones
in this study. Although we do not know if the research is
responsible for the losses, we thank those generous people for their
particiaption in research to help better the lives of others.
Leaving
ACCORD diabetes study to go Home: How to Lower Blood Sugars.
|
|